Skip to main content

Articles

Page 5 of 16

  1. With countries moving towards reaching the UNAIDS 90-90-90 goal to achieve HIV epidemic control, there are going to be an unprecedented number of persons who will need to be tested, treated, and regularly moni...

    Authors: Sowedi Muyingo, David Etoori, Paul Lotay, Samuel Malamba, James Olweny, King Keesler, Steven Wiersma, Pito Jjemba and Rashid Settaala
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:72
    Content type: Research Published on:

  2. Despite appropriate treatment of epilepsy, the treatment outcome is poor in developing country. Therefore, the study was aimed to identify the magnitude and associated factors of epileptic patients at ambulato...

    Authors: Firomsa Bekele, Tadele Mamo and Ginenus Fekadu
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:71
    Content type: Research Published on:

  3. Novel therapeutic agents for SARS-CoV-2 have emerged over time, serving to reduce the severity of the disease, admission and mortality, especially among high-risk populations. Oral nirmatrelvir/ritonavir (Paxl...

    Authors: Chee Tao Chang, Su Yin Ong, Xin Jie Lim, Lan Sim Chew and Philip Rajan
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:70
    Content type: Commentary Published on:

  4. Competitive tenders on pharmaceuticals are one of the most effective cost-containment instruments in healthcare systems. Its effectiveness has been demonstrated, among other things, in markets for generic medi...

    Authors: Lars Holger Ehlers, Morten B. Jensen and Henrik Schack
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:69
    Content type: Research Published on:

  5. In India, due to a lack of population-level financial risk protection mechanisms, the expenditure on healthcare is primarily out-of-pocket in nature. Through Drug Price Control Orders (DPCOs), the Indian Gover...

    Authors: Sakthivel Selvaraj, Habib Hasan Farooqui, Aashna Mehta and Manu Raj Mathur
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:68
    Content type: Research Published on:

  6. There is lack of both resources and expertise explains the limited extent to which pharmacoeconomic evidence is used in formulary decision-making.

    Authors: Sabaa Saleh Al‑Hemyari, Dzul Azri Mohamed Noor and Faris El‑Dahiyat
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:67
    Content type: Research Published on:

  7. The effect of the COVID-19 pandemic on the mental health of healthcare workers is gaining attention globally. This study assessed the quality-of-working life (QoWL) and prevalence of, and risk factors for anxi...

    Authors: Sherishka Dhindayal, Marothi P. Letsoalo and Tanuja N. Gengiah
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:66
    Content type: Research Published on:

  8. Ethiopia is a country with high endemicity in Hepatitis B (HepB) virus infection. However, only 14% of healthcare workers (HCWs) are currently immunized via a non-mandatory strategy in the country. Hence, this...

    Authors: Dinksew Tewuhibo, Getahun Asmamaw and Wondim Ayenew
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:65
    Content type: Research Published on:

  9. Information about how newspapers portray antidiabetic medicines to readers is lacking. This study investigated the reporting on antidiabetic medicines in the most widely circulated newspapers published in the ...

    Authors: Nadia Farhanah Syafhan, Gaoyun Chen, Carole Parsons and James C. McElnay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:64
    Content type: Research Published on:

  10. Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network. The primary object...

    Authors: Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, Hani Dimassi and Rita Karam
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:63
    Content type: Research Published on:

  11. Medication errors have serious consequences for patients’ morbidity and mortality. The involvement of pharmacy professionals in the prescribing and dispensing procedure allowed the detection of a range of drug...

    Authors: Wudneh Simegn, Berhanemeskel Weldegerima, Mohammed Seid, Ayal Zewdie, Dawit Wondimsigegn, Chilot Abyu, Asmamaw Emagn Kasahun, Abdulwase Mohammed Seid, Gashaw Sisay and Yigizie Yeshaw
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:62
    Content type: Research Published on:

  12. Medication adherence, one of the most important aspects in the process of optimal medicines use, is unfortunately still a major challenge in modern healthcare, and further research is required into how adheren...

    Authors: Nadia Farhanah Syafhan, Rosemary Donnelly, Roy Harper, Janet Harding, Ciara Mulligan, Anita Hogg, Michael Scott, Glenda Fleming, Claire Scullin, Ahmed F. Hawwa, Gaoyun Chen, Carole Parsons and James C. McElnay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:61
    Content type: Research Published on:

  13. Following the emergence of the global Coronavirus Disease-2019 (COVID-19) pandemic, alcohol-based hand sanitizers (ABHS) have been extensively used as one of the effective methods of preventing its transmissio...

    Authors: Tesfa Marew Wallelign, Muluken Nigatu Selam, Gebremariam Birhanu Wondie and Bruck Messele Habte
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:60
    Content type: Research Published on:

  14. To promote an acceptance rate of COVID-19 immunization among Thai children, concerns about parental vaccination hesitancy should be urgently studied. This study aimed to examine the parental COVID-19 vaccinati...

    Authors: Pantira Parinyarux, Kanokkarn Sunkonkit and Kitiyot Yotsombut
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:59
    Content type: Research Published on:

  15. Health supply chain systems are essential for effective and efficient healthcare system by ensuring availability of quality essential medicines and health supplies. While several interventions have been made t...

    Authors: Eric Lugada, Irene Ochola, Anthony Kirunda, Moses Sembatya, Sheila Mwebaze, Martin Olowo, Denis Okidi Ladwar and Henry Komakech
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:58
    Content type: Research Published on:

  16. Non-prescribed antibiotic use is an emerging risky practice around the globe. An inappropriate use involving nonprescription access is one cause of the rapid increase in antibiotic resistance. Children commonl...

    Authors: Dumessa Edessa, Nega Assefa, Yadeta Dessie, Fekede Asefa, Girmaye Dinsa and Lemessa Oljira
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:57
    Content type: Research Published on:

  18. Over the last decade, the use of dietary and herbal supplements (DHSs) has expanded greatly across national healthcare settings for the prevention, management and/or treatment of a variety of health issues. Al...

    Authors: Jeremy Y. Ng, Minji Kim and Ayush Suri
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:55
    Content type: Review Published on:

  19. While the widespread implementation of the non-pharmaceutical interventions was intended to contain the COVID-19 pandemic, such measures could be also effective in limiting the spread of other respiratory infe...

    Authors: Dalal Youssef, Ola Issa, Maysaloun Kanso, Janet Youssef, Linda Abou-Abbas and Edmond Abboud
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:54
    Content type: Research Published on:

  20. Pharmaceutical spending has been increasing rapidly for years and is higher than ever before. To control the rising costs, countries are implementing regulatory frameworks such as (internal) reference pricing,...

    Authors: Florian Siegmeier and Melanie Büssgen
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:53
    Content type: Research Published on:

  21. To combat the global challenge of cancer, priority has been placed on the research and development of new cancer medicines (NCMs). NCMs are often approved for marketing in accelerated processes. Despite signif...

    Authors: Eeva Ollila, Vesa Kataja and Liisa Sailas
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:52
    Content type: Research Published on:

  22. Medication administration errors are frequent and cause significant harm globally. However, only a few data are available on their prevalence, nature, and severity in developing countries, particularly in Braz...

    Authors: Lindemberg Assunção-Costa, Ivellise Costa de Sousa, Renata Kelly Rodrigues Silva, Ana Carla do Vale, Charleston Ribeiro Pinto, Juliana Ferreira Fernandes Machado, Cleidenete Gomes Valli and Luis Eugenio Portela Fernandes de Souza
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:51
    Content type: Research Published on:

  23. State capture by the pharmaceutical industry is a form of corruption whereby pharmaceutical companies shift laws or policies about their products away from the best interest of the public and toward their priv...

    Authors: Ariel Gorodensky and Jillian C. Kohler
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:50
    Content type: Research Published on:

  24. The COVID-19 pandemic has brought new situations that require the effective delivery of health information across the world and it’s important to offer clear, consistent, and credible information on the pandem...

    Authors: Belachew Umeta, Temesgen Mulugeta, Girma Mamo, Sintayehu Alemu, Nimona Berhanu, Gudina Milkessa, Birhanu Mengistu and Tsegaye Melaku
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:49
    Content type: Research Published on:

  25. Human immunodeficiency virus and acquired immunodeficiency syndrome had created enormous challenges worldwide, and continues to be the world’s serious health and development challenges. Globally, at the end 20...

    Authors: Yalemgeta Biyazin, Kalkidan Wondwossen, Azene Bantie Wubie, Melese Getachew and Bereket Gebremichael
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:48
    Content type: Research Published on:

  27. With an estimated population of 8.3 million, Sierra Leone has no existing pharmaceutical manufacturing company at present. The recent COVID-19 pandemic brought to the limelight the fragility and weakness of th...

    Authors: Eugene Conteh, Melody Okereke, Foday Umaro Turay, Alhaji Sununu Bah and Abdulwasiu Muhsinah
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:46
    Content type: Commentary Published on:

  28. Despite being the most effective treatment for advanced type 2 diabetes, the choice to start and maintain insulin therapy is based on a variety of criteria, including the patients' acceptance and willingness t...

    Authors: Ewunetie Mekashaw Bayked, Mesfin Haile Kahissay and Birhanu Demeke Workneh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:45
    Content type: Research Published on:

  29. Information is crucial in enhancing partnership, reducing uncertainties and inventory costs, improving order fulfillment, and increasing customer satisfaction. However, there is a scantiness of studies on how ...

    Authors: Yohannes Birhanu, Tafesse Gizaw, Dawit Teshome, Bekele Boche and Tadesse Gudeta
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:44
    Content type: Research Published on:

  30. Healthcare services across the world have been deeply impacted by the COVID-19 pandemic. In primary care, community pharmacists have had an important role in the frontline healthcare response to the pandemic.

    Authors: Claire Durand, Eric Douriez, Aude Chappuis, Frédérique Poulain, Yazdan Yazdanpanah, Sylvie Lariven, François-Xavier Lescure and Nathan Peiffer-Smadja
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:43
    Content type: Research Published on:

  32. Authors: Belachew Tefera, Belachew Bacha, Sileshi Belew, Rafaella Ravinetto, Tenaw Andualem, Zerihun Abegaz, Ayalew Zelelew, Gudeta Uma, Tadese Setegn, Abdisa Hunduma, Dinsefa Jemal, Diriba Daba and Bizuayehu Belete
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:41
    Content type: Correction Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2022 15:17

  33. Pharmacy practice research publications has increased significantly in the last decade. This is also true for Middle Eastern countries.

    Authors: Daneh Obaid, Faris El-Dahiyat and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:40
    Content type: Research Published on:

  34. To evaluate knowledge, attitude and perception of community pharmacists towards pharmacogenomics services.

    Authors: Usman Abubakar, Lienarrubini Subramaniam, Abdulkadir Ayinla, Mobolaji Nurudeen Ambali, Dzul Azri Mohamed Noor, Nur Aizati Athirah Daud, Hauwa Kulu Isah and Hiba A. Al-Shami
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:39
    Content type: Research Published on:

  36. Pharmacists in high-income countries routinely provide efficient pharmacy or pharmaceutical care services that are known to improve clinical, economic, and humanistic outcomes (ECHO) of patients. However, phar...

    Authors: Sunil Shrestha, Rajeev Shrestha, Ali Ahmed, Binaya Sapkota, Asmita Priyadarshini Khatiwada, Christina Malini Christopher, Parbati Thapa, Bhuvan KC, Ali Qais Blebil, Saval Khanal and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:37
    Content type: Review Published on:

  37. Despite calls for the use of additional real-world evidence (RWE) during drug development, rates of inclusion at the regulatory stage remain low. The medicine adoption model suggests that providing additional ...

    Authors: Ravi Jandhyala
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:36
    Content type: Research Published on:

  38. Asthma is a significant public health issue that poses a substantial health and economic burden. Despite the availability of effective asthma medications, its management remain suboptimal. Recent asthma guidel...

    Authors: Amira S. A. Said, Nadia Hussain, Zelal Kharaba, Amal H. I. Al Haddad, Lamiaa N. Abdelaty and Raghda R. S. Hussein
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:35
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2022 15:38

  39. COVID-19 has led to restrictions on movements and lockdown measures, which have resulted to higher utilization of over-the-counter drugs compared to prescription-only drugs. This study determined the prevalenc...

    Authors: Chidinma Ihuoma Amuzie, Kalu Ulu Kalu, Michael Izuka, Uche Ngozi Nwamoh, Uloaku Emma-Ukaegbu, Franklin Odini, Kingsley Metu, Chigozie Ozurumba and Ijeoma Nkem Okedo-Alex
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:34
    Content type: Research Published on:

  40. India, the country with the largest market availability of antimicrobial fixed-dose combinations (FDCs), banned certain antimicrobial FDCs in September 2018. Our objective was to examine the impact of Governme...

    Authors: Giorgia Sulis, Richeek Pradhan, Anita Kotwani and Sumanth Gandra
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:33
    Content type: Short report Published on:

  42. While intravenous human immunoglobulin therapy is potentially lifesaving for rare diseases, the significant costs associated with its usage warrant due attention. This study evaluated the costs and prescribing...

    Authors: Shea Jiun Choo, Chun Zheng Ng, Yi Jing Ong, Kamariah Shamsinar Kamarul Baharin and Chee Tao Chang
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:31
    Content type: Short report Published on:

  43. The use of pharmaceutical pictograms to enhance patients’ understanding of drug regimens has been proven effective in many countries. There are two reference systems for pictograms generally used in pharmacy: ...

    Authors: Margarita M. Gutierrez, Chanthawat Patikorn and Puree Anantachoti
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:30
    Content type: Research Published on:

  44. In countries with limited access to healthcare services, community pharmacists’ management of minor symptoms experienced by pregnant women could be beneficial in terms of alleviating the burden of other health...

    Authors: Asnakew Achaw Ayele, Md Shahidul Islam, Suzanne Cosh and Leah East
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:29
    Content type: Research Published on:

  45. Tension in the supply of highly consumed drugs for patients with COVID-19 (propofol, midazolam, curares) led the French government to set up a centralized supply of hospitals with distribution based on the num...

    Authors: Claire Chapuis, Rémy Collomp, Laura Albaladejo, Hugo Terrisse, Stéphane Honoré, Jean-Luc Bosson, Pierrick Bedouch and Pierre Albaladejo
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:28
    Content type: Research Published on:

  46. Canada has experienced a distinctly bifurcated pattern of (strong) opioid utilization post-2000, with multifold increases rendering it one of the world’s highest opioid consumption rates, followed by subsequen...

    Authors: Wayne Jones, Ridhwana Kaoser, David Rudoler and Benedikt Fischer
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:27
    Content type: Research Published on:

  47. People with weakened immune systems may not develop adequate protection after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may improve the level of protection against Covid-19.

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, Mustafa Habeb and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:26
    Content type: Research Published on:

  49. Community pharmacies are widely distributed in the United Arab Emirates where community pharmacists’ (CPs’) perspectives on provision of extended community pharmacy services (ECPS) is not known. This study ass...

    Authors: Subish Palaian, Muaed Alomar, Nageeb Hassan and Fatima Boura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:24
    Content type: Research Published on:

  50. Globally, hypertension is a major public health problem and a strong predictor of cardiovascular disease complications. To reduce and prevent complications from hypertension, it is important to adapt self-care...

    Authors: Tsegaye Melaku, Bodena Bayisa, Helen Fekeremaryam, Alemayehu Feyissa and Alemayehu Gutasa
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:23
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.266 - SNIP (Source Normalized Impact per Paper)
    0.574 - SJR (SCImago Journal Rank)

    2022 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    97 days submission to accept (Median)

    2022 Usage
    708,141 downloads
    5,255 Altmetric mentions

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us